Applications to this grant round should encompass a significant body of work that represents a clear and impactful progression of work conducted under the previous Quest for Cures award. Applicants should demonstrate how further investment in their research will progress further their initial ideas toward a cure for patients with brain tumours. Importantly, this mechanism will not fund completely new research ideas unconnected from the prior award, nor prolong funding for research aims proposed under the prior award.
Continued funding for collaborative multi-disciplinary teams with research ideas that will be translated to the clinic within two years of the end of the grant. The scheme aims to fund proven teams, possibly with new collaborations, who are pursuing recently revealed directions of research, or significant elaboration of previous themes, bringing benefits to patients faster.
Applications open: 02 September 2019
Application Deadline: 14 October 2019, 5pm (BST)
Funding decision: March 2020
Funding of up to £1.5 million per programme over five years is available.
Building on the previous programme grant, the new proposal should have a clear and rapid line of sight to the clinic. Multidisciplinary collobarations should be consolidated with the most talented and promising researchers across institutions to utilise technological advances across fields. The multidisciplinary team should facilitate research which would not be achievable without such a collaboration.
This funding for pre-clinical studies aims to:
This funding should be allocated to cover direct costs for staff, including salaries, consumables and publication costs. Requests for capital / infrastructure will not be considered since it is expected that this will be available at the Lead Institution as well as all partner organisations. Grants will be awarded to the Principal Investigator's institution. Funding can be allocated to co-investigator institutions with agreements put in place between all partner institutions.
To obtain input from those affected by brain tumours, we strongly recommend that applicants access our Research Involvement Network (RIN) for public and patient involvement. In order to receive feedback from the RIN, please allow for a minimum of 3 weeks turnaround time.
Applications to this grant round should encompass a significant body of work that builds on the foundations set by the previous grant. It should not simply prolong funding of the same projects.
Innovative and transformative research
Collaborative and multidisciplinary emphasis
Potential for patient benefit
Milestone and goal-driven approach
Value for money and communication plans
The Brain Tumour Charity is a member of the Association of Medical Research Charities (AMRC) and adheres to its principles of peer review. All applications will be considered by our Biomedical Scientific Advisory Board (Biomedical SAB) alongside lay representatives of people affected by brain tumours.
These grant conditions, together with the grant award letter, set out the terms and conditions on which we make a grant to the host institution and grantholder.
These guidelines explain which of the costs incurred will be paid for by The Charity
This statement details how the information you give us will be processed, used and stored in accordance with data protection legislation
Please take note of, and allow sufficient time for, the approval steps required to complete the submission process. We cannot guarantee late submissions will be accepted.
To apply for the Quest for Cures: Progression Funding grant please click the button below and complete the application process
If you would like to discuss your application or need any information, please contact the Research Team.
Phone: +44 (0) 1252 418190